Additional file 5 of Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis

Additional file 5: Table s2. Microarray-based gene expression profiling of the BLM-induced SSc model treated with MT-7117.